# Acorda Therapeutics, Inc., Pearl River, NY – FDA Inspections

Source: https://www.keypedia.com/companies/acorda-therapeutics-inc/7c9c61c1-bfd5-4162-98ba-53f58085d345

> Inspection records and compliance data for Acorda Therapeutics, Inc. in Pearl River, New York. 11 FDA inspections on record (1 OAI), last inspected August 18, 2020.

---

## Details

- Name: Acorda Therapeutics, Inc.
- FEI Number: 3002457563
- Address Line 1: 2 Blue Hill Plz Fl 3
- City: Pearl River
- State: New York
- Zip Code: 10965
- Country Name: United States
- Address: 2 Blue Hill Plz Fl 3, Pearl River, New York 10965, United States
- Country: United States

## Related Documents

- FDA Inspection 1130049 - Acorda Therapeutics, Inc. - 2020-08-18 — classification: No Action Indicated (NAI), source: FDA, date: August 18, 2020
- FDA Inspection 1100682 - Acorda Therapeutics, Inc. - 2019-07-19 — classification: No Action Indicated (NAI), source: FDA, date: July 19, 2019
- FDA Inspection 1079179 - Acorda Therapeutics, Inc. - 2019-01-18 — classification: No Action Indicated (NAI), source: FDA, date: January 18, 2019
- [FDA Inspection 975465 - Acorda Therapeutics, Inc. - 2016-02-29](https://www.keypedia.com/records/fda_inspections/acorda-therapeutics-inc/cf8499af-5eb6-4f09-a629-8159efe95e03) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 29, 2016
- FDA Inspection 892026 - Acorda Therapeutics, Inc. - 2014-08-25 — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 25, 2014
- [FDA Inspection 860326 - Acorda Therapeutics, Inc. - 2013-12-19](https://www.keypedia.com/records/fda_inspections/acorda-therapeutics-inc/32a52921-3d1f-48e6-8f3a-3b4a701fb314) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 19, 2013
- [FDA Inspection 812545 - Acorda Therapeutics, Inc. - 2013-01-16](https://www.keypedia.com/records/fda_inspections/acorda-therapeutics-inc/22597b33-daba-4d73-a6cd-eb95fdbfe6d7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 16, 2013
- FDA Inspection 812547 - Acorda Therapeutics, Inc. - 2012-12-07 — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 7, 2012
- [FDA Inspection 739375 - Acorda Therapeutics, Inc. - 2011-09-09](https://www.keypedia.com/records/fda_inspections/acorda-therapeutics-inc/bc21c245-952e-45c0-ab6e-a9fbc9f76afb) — classification: Official Action Indicated (OAI), source: FDA, date: September 9, 2011
- FDA Inspection 739376 - Acorda Therapeutics, Inc. - 2011-08-11 — classification: No Action Indicated (NAI), source: FDA, date: August 11, 2011

## Related Companies

- [Naveed Iqbal, M.D.](https://www.keypedia.com/companies/naveed-iqbal-md/b182c52f-fb6e-4841-a03e-76bc6a807bd7)
- [Marksans Pharmaceuticals  Ltd](https://www.keypedia.com/companies/marksans-pharmaceuticals-ltd/8c0e52f9-2d1d-4e90-814f-c4758f55ea89)
- [Jared C. Barlow, M.D.](https://www.keypedia.com/companies/jared-c-barlow-md/37392cc0-6de0-437b-8866-c35670f09521)
- [Miguel-Angel Perales, MD](https://www.keypedia.com/companies/miguel-angel-perales-md/ace7ffc3-fe44-4728-8019-7b5f8f62a90c)
- [Ellen Ritchie, MD](https://www.keypedia.com/companies/ellen-ritchie-md/82b3b4e8-cc39-4644-9bb2-b18f28e66ce1)
- [Albany College Pharmacy IRB](https://www.keypedia.com/companies/albany-college-pharmacy-irb/bc3122d3-4a0d-49d0-aee0-13b31a45a43e)
- [William M. Kufs, MD](https://www.keypedia.com/companies/william-m-kufs-md/6ced0cc5-de36-40bf-9ebc-fc05aa0d10d5)
- [Charles Marmar, M.D.](https://www.keypedia.com/companies/charles-marmar-md/5c9d4d41-5ddd-4dd1-9646-3725b0f21963)
- [Paula J. Busse, M.D.](https://www.keypedia.com/companies/paula-j-busse-md/42ffaa95-1f44-4f25-af1d-4c6febb7da14)
- [Scott T. Tagawa, M.D.](https://www.keypedia.com/companies/scott-t-tagawa-md/2c3f0b86-ec04-40ff-94d3-2dd63446ea85)